Literature DB >> 9597979

Medical treatment of essential tremor and Parkinson's disease.

R J Uitti1.   

Abstract

Although there is no known cure for essential tremor or Parkinson's disease (PD), medical treatment can often significantly reduce or eliminate functional disability. Mild essential tremor does not require treatment, and early treatment does not arrest or slow the natural progression in symptoms. When essential tremor interferes with daily activities, medical treatment options include beta blockers, anticonvulsants, benzodiazepines, and carbonic anhydrase inhibitors. Because of the great variability in the presentation of PD, no single approach is appropriate for all patients. Levodopa is the mainstay of pharmacologic therapy for PD, although other agents are indicated for monotherapy or in combination with levodopa. These include traditional and newer dopamine agonists, amantadine, anticholinergics, selegiline, and an emerging class of agents called COMT inhibitors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597979

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  4 in total

1.  The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.

Authors:  Jillian G Baker
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 2.  Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.

Authors:  Jillian G Baker; Stephen J Hill; Roger J Summers
Journal:  Trends Pharmacol Sci       Date:  2011-03-21       Impact factor: 14.819

3.  Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.

Authors:  Jillian G Baker; Philip Kemp; Julie March; Laurice Fretwell; Stephen J Hill; Sheila M Gardiner
Journal:  FASEB J       Date:  2011-08-24       Impact factor: 5.191

Review 4.  Beta-blocker therapy for tremor in Parkinson's disease.

Authors:  N J Crosby; K H O Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.